AMLX
NASDAQStockAmylyx Pharmaceuticals, Inc.
$14.39-0.54 (-3.58%)
52-Week Range
$3.31
$16.92
Key Stats
Market Cap
1.2B
P/E Ratio
N/A
Dividend Yield
N/A
Beta
-0.30
Volume
627.3K
Avg Volume
1.1M
Performance
1M
-3.43%
3M
+9.77%
6M
+21.35%
YTD
+25.92%
1Y
+267.77%
3Y
-53.87%
5Y
-20.42%
Price Chart
ETF Exposure
AMLX is held by 63 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| XPH | State Street SPDR S&P Pharmaceuticals ETF | 2.20% |
| SBIO | ALPS Medical Breakthroughs ETF | 1.05% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.85% |
| FMED | FIDELITY DISRUPTIVE MEDICINE ETF | 0.51% |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X ETF | 0.43% |
| IHE | iShares U.S. Pharmaceuticals ETF | 0.33% |
| IWC | iShares Micro-Cap ETF | 0.28% |
| VFMO | Vanguard U.S. Momentum Factor ETF | 0.16% |
| HEAL.L | iShares Healthcare Innovation UCITS ETF | 0.12% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.12% |
| IBB | iShares Biotechnology ETF | 0.12% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | 0.10% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.09% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.08% |
| PRFZ | Invesco RAFI US 1500 Small-Mid ETF | 0.07% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 0.07% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.07% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.06% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.06% |
| IWM | iShares Russell 2000 ETF | 0.04% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.04% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.04% |
| VTWO | Vanguard Russell 2000 ETF | 0.04% |
| RSSL | Global X - Russell 2000 ETF | 0.04% |
| SMLF | iShares U.S. Small-Cap Equity Factor ETF | 0.04% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.03% |
| UWM | ProShares - Ultra Russell2000 | 0.03% |
| URTY | ProShares - UltraPro Russell2000 | 0.03% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.02% |
| IWN | iShares Russell 2000 Value ETF | 0.02% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.02% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.02% |
| VHT | Vanguard Health Care ETF | 0.02% |
| FHLC | FIDELITY MSCI HEALTH CARE INDEX ETF | 0.01% |
| VXF | Vanguard Extended Market ETF | 0.01% |
| WSML | iShares MSCI World Small-Cap ETF | 0.01% |
| SMMD | iShares Russell 2500 ETF | 0.01% |
| HDG | ProShares - Hedge Replication ETF | 0.01% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.01% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.01% |
| DCOR | Dimensional - US Core Equity 1 ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IWV | iShares Russell 3000 ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| EAOA | iShares ESG Aware 80/20 Aggressive Allocation ETF | 0.00% |
Page 1 of 2Next
About AMLX ETF Exposure
Amylyx Pharmaceuticals, Inc. (AMLX) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.2B, AMLX is a widely held institutional stock. The stock currently trades at $14.39. Investors can gain exposure to AMLX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold AMLX, sorted by portfolio weight.